Literature DB >> 19578390

Anticitrullinated protein/peptide antibodies in rheumatoid arthritis.

Wolfgang L Gross, Frank Moosig, Peter Lamprecht.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19578390      PMCID： PMC2695366          DOI： 10.3238/arztebl.2009.0157

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  12 in total

1.  Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.

Authors:  Linda Mathsson; Mohammed Mullazehi; Marius C Wick; Olof Sjöberg; Ronald van Vollenhoven; Lars Klareskog; Johan Rönnelid
Journal:  Arthritis Rheum       Date:  2008-01

2.  Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial.

Authors:  Yvonne P M Goekoop-Ruiterman; Jeska K de Vries-Bouwstra; Cornelia F Allaart; Derkjen van Zeben; Pit J S M Kerstens; J Mieke W Hazes; Aelko H Zwinderman; André J Peeters; Johanna M de Jonge-Bok; Constant Mallée; Wim M de Beus; Peter B J de Sonnaville; Jacques A P M Ewals; Ferdinand C Breedveld; Ben A C Dijkmans
Journal:  Ann Intern Med       Date:  2007-03-20       Impact factor: 25.391

Review 3.  The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens.

Authors:  Karl Egerer; Eugen Feist; Gerd-Rüdiger Burmester
Journal:  Dtsch Arztebl Int       Date:  2009-03-06       Impact factor: 5.594

4.  Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.

Authors:  Holger Bang; Karl Egerer; Anke Gauliard; Kirsten Lüthke; Paul E Rudolph; Gert Fredenhagen; Wigbert Berg; Eugen Feist; Gerd-R Burmester
Journal:  Arthritis Rheum       Date:  2007-08

5.  Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.

Authors:  Paul Emery; Ferdinand C Breedveld; Stephen Hall; Patrick Durez; David J Chang; Deborah Robertson; Amitabh Singh; Ronald D Pedersen; Andrew S Koenig; Bruce Freundlich
Journal:  Lancet       Date:  2008-07-16       Impact factor: 79.321

6.  Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.

Authors:  Dan Caspi; Marina Anouk; Itzhak Golan; Daphna Paran; Ilana Kaufman; Irena Wigler; David Levartovsky; Irena Litinsky; Ori Elkayam
Journal:  Arthritis Rheum       Date:  2006-02-15

7.  Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.

Authors:  O Meyer; C Labarre; M Dougados; Ph Goupille; A Cantagrel; A Dubois; P Nicaise-Roland; J Sibilia; B Combe
Journal:  Ann Rheum Dis       Date:  2003-02       Impact factor: 19.103

Review 8.  The immune response to citrullinated proteins in patients with rheumatoid arthritis: genetic, clinical, technical, and epidemiological aspects.

Authors:  Allan S Wiik
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

9.  Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis.

Authors:  Tracey M Farragher; Nicola J Goodson; Haris Naseem; Alan J Silman; Wendy Thomson; Deborah Symmons; Anne Barton
Journal:  Arthritis Rheum       Date:  2008-02

Review 10.  Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets.

Authors:  Annette H M van der Helm-van Mil; Tom W J Huizinga
Journal:  Arthritis Res Ther       Date:  2008-03-31       Impact factor: 5.156
View more
  2 in total

1.  [Positions for medical doctors in German hospitals for psychiatry and psychotherapy].

Authors:  M Grözinger; J Amlacher; F Schneider
Journal:  Nervenarzt       Date:  2011-11       Impact factor: 1.214

2.  Antibodies to mutated citrullinated vimentin in rheumatoid arthritis: diagnostic value, association with radiological damage and axial skeleton affection.

Authors:  Howaida E Mansour; Khaled M Metwaly; Iman A Hassan; Hebat-Allah A Elshamy; Moataz M S Elbeblawy
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2010-05-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.